Annual Report/Annual ResultsMeVis publishes figures for fiscal year 2023/2024 and forecast for 2024/2025 30.01.2025 / 12:00 CET/CESTThe issuer is solely responsible for the content of this ...

Takeda (TOKYO:4502/NYSE:TAK) today announced earnings results for the third quarter of fiscal year 2024 (nine months ended ...

Leprosy, caused by Mycobacterium leprae, is a chronic but curable infectious disease affecting the skin, nerves, and ...

Arne Slot's Liverpool are clear favourites for the Premier League title, though they face a tricky trip to the south coast ...

Indian Oil Corporation (IOC) reported a smaller-than-expected profit for the quarter, citing reduced margins and losses in its LPG business as the primary reasons. The company faced challenges from ...

In the assessment of 12-month price targets, analysts unveil insights for Arcturus Therapeutics, presenting an average target ...

Among patients with resected gallbladder cancer, the addition of chemoradiation to chemotherapy treatment did not improve ...

The phrase 'home truths' took on a different meaning for Arne Slot this week when he picked up the phone to speak to his ...

Ophthalmologists must know how to identify and manage pseudoexfoliation glaucoma, one of the most damaging forms of the ...

In a report released yesterday, Mohit Bansal from Wells Fargo maintained a Buy rating on Gilead Sciences (GILD – Research Report), with a price ...

Corcept Therapeutics' long-term goal is $3 billion revenue by 2029, driven by the new drug Relacorilant. Click here to read ...